TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism

Toll-like receptor 9 (TLR9) triggering is a promising novel strategy to combat cancer as it induces innate and adaptive immunity responses. B-cell lymphoma is unique in this context as tumor cells express TLR9 and may harbor latent Epstein-Barr virus (EBV), a gamma-herpesvirus with remarkable oncoge...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Noack, J, Jordi, M, Zauner, L, Alessi, D, Burch, A, Tinguely, M, Hersberger, M, Bernasconi, M, Nadal, D
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2012
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3388232/
https://ncbi.nlm.nih.gov/pubmed/22717578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2012.60
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak